Qiagen : Re-igniting the growth engine mid-term, benefitting from coronavirus short-term
>Strong finish to 2021 also bodes well for start of 2022 - Q4 2021 was a strong quarter with sales of $ 582m having beaten our forecast by 4% and consensus (FactSet) by 10%. Both Covid-related product sales and non-COVID related product sales surprised positively. Looking at COVID-related product sales, we note that Q4 sales came in well above the trough levels from Q2 and Q3 (c. $ 160m) at $ 183m. Non-Covid related sales grew at c. 8% y-o-y against an already high ba...Qiagen is provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. Co.'s sample technologies process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software interprets data. Automation solutions unite these together in molecular testing workflows. Co. provides these workflows to four classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Co. markets its products in more than 130 countries.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.